Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Ppublish 67 citations
PubMed: 38424454 DOI: 10.1038/s41582-024-00940-4
Is Alzheimer disease a disease?
Nat Rev Neurol 20(4):245-251
Authors: Amos D Korczyn, Lea T Grinberg
Affiliations
- Departments of Neurology, Physiology and Pharmacology, Tel Aviv University, Tel Aviv, Israel.
- Departments of Neurology and Pathology, UCSF, San Francisco, CA, USA.
- Global Brain Health Institute, UCSF, San Francisco, CA, USA.
- Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil.
Abstract
Dementia, a prevalent condition among older individuals, has profound societal implications. Extensive research has resulted in no cure for what is perceived as the most common dementing illness: Alzheimer disease (AD). AD is defined by specific brain abnormalities - amyloid-β plaques and tau protein neurofibrillary tangles - that are proposed to actively influence the neurodegenerative process. However, conclusive evidence of amyloid-β toxicity is lacking, the mechanisms leading to the accumulation of plaques and tangles are unknown, and removing amyloid-β has not halted neurodegeneration. So, the question remains, are we making progress towards a solution? The complexity of AD is underscored by numerous genetic and environmental risk factors, and diverse clinical presentations, suggesting that AD is more akin to a syndrome than to a traditional disease, with its pathological manifestation representing a convergence of pathogenic pathways. Therefore, a solution requires a multifaceted approach over a single 'silver bullet'. Improved recognition and classification of conditions that converge in plaques and tangle accumulation and their treatment requires the use of multiple strategies simultaneously.
MeSH
Amyloid, Alzheimer Disease, Nervous System Diseases
Cited by
- Challenges in a Biological Definition of Alzheimer Disease. Neurology, 2024
- Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes. Future Med Chem, 2024
- Research models to study lewy body dementia. Mol Neurodegener, 2025
- Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies. J Neurol, 2024
- The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer's Disease: A Review. Foods, 2025
- Drug repurposing for Alzheimer's disease and other neurodegenerative disorders. Nat Commun, 2025
- Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy. Acta Pharm Sin B, 2025
- Considering challenges for the new Alzheimer's drugs: Clinical, population, and health system perspectives. Alzheimers Dement, 2024
- Development of donepezil hydrochloride-loaded PLGA-based nanoparticles for Alzheimer's disease treatment. Sci Rep, 2025
- Dementia risk reduction in the African context: Multi-national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa-FINGERS project). Alzheimers Dement, 2024
- Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease. Neurotherapeutics, 2025
- Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders. Drugs, 2024
- Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron-glia crosstalk in Alzheimer's disease. Front Pharmacol, 2025
- Peripheral proteinopathy in neurodegenerative diseases. Transl Neurodegener, 2025
- Virtual screening, ADMET prediction, molecular docking, and dynamic simulation studies of natural products as BACE1 inhibitors for the management of Alzheimer's disease. Sci Rep, 2024
- Brain change trajectories in healthy adults correlate with Alzheimer's related genetic variation and memory decline across life. Nat Commun, 2024
- Editorial: The role of neuroimaging and neurostimulation in detecting and treating Alzheimer's disease and mild cognitive impairment. Front Hum Neurosci, 2024
- Extracellular particles: emerging insights into central nervous system diseases. J Nanobiotechnology, 2025
- Slow wave synchrony during NREM sleep tracks cognitive impairment in prodromal Alzheimer's disease. Alzheimers Dement, 2025
- Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer's disease. Mol Neurodegener, 2025